← Eichor
Condition: Ibs D Diarrhea Predominant Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Ibs D Diarrhea Predominant

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome
Phase 3 · 10 location(s) · Biocodex · NCT07168434Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome
NA · 12 location(s) · Devintec Sagl · NCT06681012Evaluation of the Efficacy and Safety of Gelsectan in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome
NA · 1 location(s) · University Medical Center Ho Chi Minh City (UMC) · NCT07000383Repeated Transcranial Magnetic Stimulation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Randomi
NA · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07581756Efficacy of Rifaximin With NAC in IBS-D
Phase 2 · 1 location(s) · Mark Pimentel, MD · NCT06727422Efficacy of Repeated Transcranial Magnetic Stimulation Combined With a Live Probiotic Tablet (Combined Bifidobacterium,
Phase 1 · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT06960369
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.